Cargando…
Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study
BACKGROUND: Active surveillance (AS) for low-risk prostate cancer (PCa) appears to provide excellent long-term PCa-specific and overall survival. The choice for AS as initial treatment is mainly based on avoiding side effects from invasive treatment; but AS entails regular check-ups and the possibil...
Autores principales: | Drost, Frank-Jan H., Rannikko, Antti, Valdagni, Riccardo, Pickles, Tom, Kakehi, Yoshiyuki, Remmers, Sebastiaan, van der Poel, Henk G., Bangma, Chris H., Roobol, Monique J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861273/ https://www.ncbi.nlm.nih.gov/pubmed/29594024 http://dx.doi.org/10.21037/tau.2017.12.28 |
Ejemplares similares
-
What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study
por: Luiting, H. B., et al.
Publicado: (2021) -
Are we Overdiagnosing Bipolar Disorder?
por: Reddy, M. S., et al.
Publicado: (2017) -
Is Penile Doppler Ultrasonography Overdiagnosed?
por: Salman, Mehmet Y, et al.
Publicado: (2023) -
Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform †
por: Beyer, Katharina, et al.
Publicado: (2022) -
Personalized strategies in population screening for prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2020)